首页 > 最新文献

African Journal of Laboratory Medicine最新文献

英文 中文
Lessons learnt from assessing and improving accuracy and positive predictive value of the national HIV testing algorithm in Nigeria. 从评估和提高尼日利亚国家艾滋病毒检测算法的准确性和阳性预测值中汲取的经验教训。
IF 1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-28 eCollection Date: 2024-01-01 DOI: 10.4102/ajlm.v13i1.2339
Augustine O Mpamugo, Nnaemeka C Iriemenam, Adebobola Bashorun, Olumide O Okunoye, Orji O Bassey, Edewede Onokevbagbe, Tapdiyel Jelpe, Matthias A Alagi, Chidozie Meribe, Rose E Aguolu, Charles E Nzelu, Segun Bello, Babatunde Ezra, Christine A Obioha, Baffa S Ibrahim, Oluwasanmi Adedokun, Akudo Ikpeazu, Chikwe Ihekweazu, Talishiea Croxton, Sylvia B Adebajo, McPaul I J Okoye, Alash'le Abimiku

Background: HIV testing remains an entry point into HIV care and treatment services. In 2007, Nigeria adopted and implemented a two-test rapid HIV testing algorithm of three HIV rapid test kits, following the sequence: Alere Determine (first test), UnigoldTM (second test), and STAT-PAK® as the tie-breaker. Sub-analysis of the 2018 Nigeria HIV/AIDS Indicator and Impact Survey data showed significant discordance between the first and second tests, necessitating an evaluation of the algorithm. This manuscript highlights lessons learnt from that evaluation.

Intervention: A two-phased evaluation method was employed, including abstraction and analysis of retrospective HIV testing data from January 2017 to December 2019 from 24 selected sites supported by the United States President's Emergency Plan for AIDS Relief programme. A prospective evaluation of HIV testing was done among 2895 consecutively enrolled and consented adults, aged 15-64 years, accessing HIV testing services from three selected sites per state across the six geopolitical zones of Nigeria between July 2020 and September 2020. The prospective evaluation was performed both in the field and at the National Reference Laboratory under controlled laboratory conditions. Stakeholder engagements, strategic selection and training of study personnel, and integrated supportive supervision were employed to assure the quality of evaluation procedures and outcomes.

Lessons learnt: The algorithm showed higher sensitivity and specificity in the National Reference Laboratory compared with the field. The approaches to quality assurance were integral to the high-quality study outcomes.

Recommendations: We recommend comparison of testing algorithms under evaluation against a gold standard.

What this study adds: This study provides context-specific considerations in using World Health Organization recommendations to evaluate the Nigerian national HIV rapid testing algorithm.

背景:艾滋病毒检测仍然是艾滋病毒护理和治疗服务的切入点。2007 年,尼日利亚通过并实施了一种由三种艾滋病毒快速检测试剂盒组成的两测艾滋病毒快速检测算法,其顺序为:Alere Determine(第一测)、UnigoldTM(第二测)和 STAT-PAK®:Alere Determine(第一次检测)、UnigoldTM(第二次检测)和STAT-PAK®作为平局者。对 2018 年尼日利亚艾滋病毒/艾滋病指标和影响调查数据的子分析表明,第一次和第二次检测之间存在明显的不一致,因此有必要对该算法进行评估。本手稿重点介绍了从评估中汲取的经验教训:采用了两阶段评估方法,包括从美国总统艾滋病紧急救援计划支持的 24 个选定地点抽取和分析 2017 年 1 月至 2019 年 12 月的回顾性 HIV 检测数据。2020 年 7 月至 2020 年 9 月期间,在尼日利亚 6 个地缘政治区内每个州的 3 个选定地点,对 2895 名连续登记并同意接受艾滋病毒检测服务的 15-64 岁成年人进行了艾滋病毒检测前瞻性评估。前瞻性评估在实地和国家参考实验室的受控实验室条件下进行。为确保评估程序和结果的质量,还采用了利益相关者参与、战略性选择和培训研究人员以及综合支持性监督等方法:与现场相比,国家参考实验室的算法显示出更高的灵敏度和特异性。质量保证方法是高质量研究成果不可或缺的一部分:建议:我们建议将评估中的检测算法与黄金标准进行比较:这项研究提供了在使用世界卫生组织的建议评估尼日利亚国家 HIV 快速检测算法时的具体考虑因素。
{"title":"Lessons learnt from assessing and improving accuracy and positive predictive value of the national HIV testing algorithm in Nigeria.","authors":"Augustine O Mpamugo, Nnaemeka C Iriemenam, Adebobola Bashorun, Olumide O Okunoye, Orji O Bassey, Edewede Onokevbagbe, Tapdiyel Jelpe, Matthias A Alagi, Chidozie Meribe, Rose E Aguolu, Charles E Nzelu, Segun Bello, Babatunde Ezra, Christine A Obioha, Baffa S Ibrahim, Oluwasanmi Adedokun, Akudo Ikpeazu, Chikwe Ihekweazu, Talishiea Croxton, Sylvia B Adebajo, McPaul I J Okoye, Alash'le Abimiku","doi":"10.4102/ajlm.v13i1.2339","DOIUrl":"10.4102/ajlm.v13i1.2339","url":null,"abstract":"<p><strong>Background: </strong>HIV testing remains an entry point into HIV care and treatment services. In 2007, Nigeria adopted and implemented a two-test rapid HIV testing algorithm of three HIV rapid test kits, following the sequence: Alere Determine (first test), Unigold<sup>TM</sup> (second test), and STAT-PAK<sup>®</sup> as the tie-breaker. Sub-analysis of the 2018 Nigeria HIV/AIDS Indicator and Impact Survey data showed significant discordance between the first and second tests, necessitating an evaluation of the algorithm. This manuscript highlights lessons learnt from that evaluation.</p><p><strong>Intervention: </strong>A two-phased evaluation method was employed, including abstraction and analysis of retrospective HIV testing data from January 2017 to December 2019 from 24 selected sites supported by the United States President's Emergency Plan for AIDS Relief programme. A prospective evaluation of HIV testing was done among 2895 consecutively enrolled and consented adults, aged 15-64 years, accessing HIV testing services from three selected sites per state across the six geopolitical zones of Nigeria between July 2020 and September 2020. The prospective evaluation was performed both in the field and at the National Reference Laboratory under controlled laboratory conditions. Stakeholder engagements, strategic selection and training of study personnel, and integrated supportive supervision were employed to assure the quality of evaluation procedures and outcomes.</p><p><strong>Lessons learnt: </strong>The algorithm showed higher sensitivity and specificity in the National Reference Laboratory compared with the field. The approaches to quality assurance were integral to the high-quality study outcomes.</p><p><strong>Recommendations: </strong>We recommend comparison of testing algorithms under evaluation against a gold standard.</p><p><strong>What this study adds: </strong>This study provides context-specific considerations in using World Health Organization recommendations to evaluate the Nigerian national HIV rapid testing algorithm.</p>","PeriodicalId":45412,"journal":{"name":"African Journal of Laboratory Medicine","volume":"13 1","pages":"2339"},"PeriodicalIF":1.0,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11369579/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of ACE2 and TMPRSS2 polymorphisms in clinical severity and outcomes of COVID-19 in Egypt. ACE2和TMPRSS2多态性在埃及COVID-19临床严重程度和预后中的作用。
IF 1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-27 eCollection Date: 2024-01-01 DOI: 10.4102/ajlm.v13i1.2375
Walaa Samy, Osama A Gaber, Rania M Amer, Nahawand A El-Deeb, Ahmed A Abdelmoaty, Ahmed L Sharaf, Ahmed M El-Gebaly, Rasha Mosbah, Maha E Alsadik, Amal Fawzy, Alshymaa A Ahmed

Background: The clinical presentations of coronavirus disease 2019 (COVID-19) exhibit significant variation, ranging from asymptomatic cases to mortality resulting from severe pneumonia. Host genetics can partially explain this variation.

Objective: This study evaluated possible associations between severity and outcome of COVID-19 and single nucleotide polymorphism (SNP) rs2285666 in the ACE2 gene and SNP rs2070788 in the TMPRSS2 gene.

Methods: The study included a sample of 100 consecutive adult patients admitted to the COVID-19 Isolation and Intensive Care Units of the Zagazig University Hospitals, Zagazig, Egypt from July 2021 to November 2021. For rs2285666, polymerase chain reaction-restriction fragment length polymorphism was carried out. For rs2070788, real-time polymerase chain reaction was performed.

Results: For rs2285666, the GA genotype was the most frequent among female patients (39% [16/41]) and the A genotype was more prevalent among male patients (54.2% [32/59]). For rs2070788, the AA genotype was the most frequent among all patients (46% [46/100]). No rs2285666 or rs2070788 genotypes or allele frequencies had significant associations with either severity or outcomes of patients.

Conclusion: This study found no significant associations of COVID-19 severity or outcomes of patients with genotypes or allele frequencies of the rs2285666 SNP in the ACE2 gene or the rs2070788 SNP of the TMPRSS2 gene. The search for other genetic associations with COVID-19 infection is still required.

What this study adds: The study reveals that host genetics explain the variation observed in the disease. Specific genetic variants can confer either increased susceptibility or resistance to the disease.

背景:冠状病毒病 2019(COVID-19)的临床表现差异很大,从无症状病例到重症肺炎导致的死亡不等。宿主遗传学可以部分解释这种差异:本研究评估了 COVID-19 的严重程度和结局与 ACE2 基因中的单核苷酸多态性(SNP)rs2285666 和 TMPRSS2 基因中的 SNP rs2070788 之间可能存在的关联:研究对象包括 2021 年 7 月至 2021 年 11 月期间在埃及萨加齐格市萨加齐格大学医院 COVID-19 隔离室和重症监护室连续住院的 100 名成年患者。对 rs2285666 进行了聚合酶链式反应-限制性片段长度多态性分析。对于 rs2070788,则进行了实时聚合酶链反应:结果:对于 rs2285666,GA 基因型在女性患者中最为常见(39% [16/41]),而 A 基因型在男性患者中更为普遍(54.2% [32/59])。就 rs2070788 而言,AA 基因型在所有患者中最为常见(46% [46/100])。rs2285666或rs2070788的基因型或等位基因频率与患者的严重程度或预后均无显著关联:本研究发现,COVID-19 的严重程度或患者的预后与 ACE2 基因的 rs2285666 SNP 或 TMPRSS2 基因的 rs2070788 SNP 的基因型或等位基因频率均无明显关联。本研究还需要寻找与COVID-19感染相关的其他基因:这项研究揭示了宿主遗传学可以解释在该疾病中观察到的变异。特定的基因变异可增加对该疾病的易感性或抵抗力。
{"title":"Role of <i>ACE2</i> and <i>TMPRSS2</i> polymorphisms in clinical severity and outcomes of COVID-19 in Egypt.","authors":"Walaa Samy, Osama A Gaber, Rania M Amer, Nahawand A El-Deeb, Ahmed A Abdelmoaty, Ahmed L Sharaf, Ahmed M El-Gebaly, Rasha Mosbah, Maha E Alsadik, Amal Fawzy, Alshymaa A Ahmed","doi":"10.4102/ajlm.v13i1.2375","DOIUrl":"10.4102/ajlm.v13i1.2375","url":null,"abstract":"<p><strong>Background: </strong>The clinical presentations of coronavirus disease 2019 (COVID-19) exhibit significant variation, ranging from asymptomatic cases to mortality resulting from severe pneumonia. Host genetics can partially explain this variation.</p><p><strong>Objective: </strong>This study evaluated possible associations between severity and outcome of COVID-19 and single nucleotide polymorphism (SNP) rs2285666 in the <i>ACE2</i> gene and SNP rs2070788 in the <i>TMPRSS2</i> gene.</p><p><strong>Methods: </strong>The study included a sample of 100 consecutive adult patients admitted to the COVID-19 Isolation and Intensive Care Units of the Zagazig University Hospitals, Zagazig, Egypt from July 2021 to November 2021. For rs2285666, polymerase chain reaction-restriction fragment length polymorphism was carried out. For rs2070788, real-time polymerase chain reaction was performed.</p><p><strong>Results: </strong>For rs2285666, the GA genotype was the most frequent among female patients (39% [16/41]) and the A genotype was more prevalent among male patients (54.2% [32/59]). For rs2070788, the AA genotype was the most frequent among all patients (46% [46/100]). No rs2285666 or rs2070788 genotypes or allele frequencies had significant associations with either severity or outcomes of patients.</p><p><strong>Conclusion: </strong>This study found no significant associations of COVID-19 severity or outcomes of patients with genotypes or allele frequencies of the rs2285666 SNP in the <i>ACE2</i> gene or the rs2070788 SNP of the <i>TMPRSS2</i> gene. The search for other genetic associations with COVID-19 infection is still required.</p><p><strong>What this study adds: </strong>The study reveals that host genetics explain the variation observed in the disease. Specific genetic variants can confer either increased susceptibility or resistance to the disease.</p>","PeriodicalId":45412,"journal":{"name":"African Journal of Laboratory Medicine","volume":"13 1","pages":"2375"},"PeriodicalIF":1.0,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11369560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic susceptibility pattern among children admitted to a hospital in Nigeria: A retrospective study. 尼日利亚一家医院收治的儿童对抗生素的敏感性模式:一项回顾性研究。
IF 1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-20 eCollection Date: 2024-01-01 DOI: 10.4102/ajlm.v13i1.2362
Aderonke O Oluwo, Mary A Lawal, Cecilia A Mabogunje, Olubunmi T Okurame

Background: The impact of antimicrobial resistance on children living in resource-limited countries has been underreported, despite its established global threat.

Objective: This retrospective study aimed to describe the trend of antibiotic susceptibility in the paediatric age group.

Methods: Sensitivity test report data consisting of 300 paediatric patients aged 18 hours to 192 months were retrieved from the microbiology laboratory records at a state-owned children's hospital in Nigeria over a period of 4 months starting from December 2021 to March 2022. Five genera (Escherichia coli, Klebsiella spp., Pseudomonas spp., Staphylococcus aureus and Streptococcus spp.) were cultured as recommended by the Clinical Laboratory Standard Institute, using the Kirby Bauer disc diffusion method. Antimicrobial susceptibility testing was carried out on isolates using 15 different antibiotics.

Results: Staphylococcus aureus was the most frequent pathogen isolated 32.1% (50/156) and Pseudomonas spp. was the least frequent pathogen isolated 7.1% (11/156) in all samples. The isolates with the highest rate of resistance to the tested antibiotics were S. aureus 32.1% (50/156), E. coli 28.2% (44/156) and Klebsiella spp. 20.5% (32/156). Isolates in all age groups were more resistant to ampicillin, amoxicillin + clavulanic acid, cefuroxime and cefepime.

Conclusion: Antibiotic resistance is high, especially the younger Nigerian children. Strict antibiotic protocols should be adhered to especially in the use of empirical antibiotic therapy in hospitals.

What this study adds: Our study reveals a higher trend of antibiotic resistance, especially in younger children. It further shows that the pathogens are most resistant to the most available empirical antibiotics in Nigeria.

背景:尽管抗生素耐药性已成为全球性威胁,但它对资源有限国家儿童的影响却未得到充分报道:抗菌药耐药性对生活在资源有限国家的儿童的影响一直未得到充分报道,尽管它已成为全球性威胁:这项回顾性研究旨在描述儿科抗生素敏感性的变化趋势:从 2021 年 12 月至 2022 年 3 月的 4 个月期间,从尼日利亚一家国有儿童医院的微生物实验室记录中检索了 300 名年龄在 18 小时至 192 个月之间的儿科患者的药敏试验报告数据。按照临床实验室标准研究所的建议,使用柯比鲍尔盘扩散法对五个菌属(大肠埃希菌、克雷伯氏菌属、假单胞菌属、金黄色葡萄球菌和链球菌属)进行了培养。使用 15 种不同的抗生素对分离物进行了抗菌药敏感性测试:结果:在所有样本中,金黄色葡萄球菌是最常分离到的病原体,占 32.1%(50/156),假单胞菌属是最少分离到的病原体,占 7.1%(11/156)。对测试抗生素耐药率最高的分离株是金黄色葡萄球菌 32.1%(50/156)、大肠杆菌 28.2%(44/156)和克雷伯菌属 20.5%(32/156)。所有年龄组的菌株对氨苄西林、阿莫西林+克拉维酸、头孢呋辛和头孢吡肟的耐药性都较强:结论:抗生素耐药性很高,尤其是尼日利亚的年轻儿童。结论:抗生素耐药性很高,尤其是年幼的尼日利亚儿童,应严格遵守抗生素使用规范,特别是在医院使用经验性抗生素治疗时:我们的研究显示,抗生素耐药性呈上升趋势,尤其是在年幼儿童中。研究进一步表明,病原体对尼日利亚最常用的经验性抗生素的耐药性最强。
{"title":"Antibiotic susceptibility pattern among children admitted to a hospital in Nigeria: A retrospective study.","authors":"Aderonke O Oluwo, Mary A Lawal, Cecilia A Mabogunje, Olubunmi T Okurame","doi":"10.4102/ajlm.v13i1.2362","DOIUrl":"10.4102/ajlm.v13i1.2362","url":null,"abstract":"<p><strong>Background: </strong>The impact of antimicrobial resistance on children living in resource-limited countries has been underreported, despite its established global threat.</p><p><strong>Objective: </strong>This retrospective study aimed to describe the trend of antibiotic susceptibility in the paediatric age group.</p><p><strong>Methods: </strong>Sensitivity test report data consisting of 300 paediatric patients aged 18 hours to 192 months were retrieved from the microbiology laboratory records at a state-owned children's hospital in Nigeria over a period of 4 months starting from December 2021 to March 2022. Five genera (<i>Escherichia coli, Klebsiella</i> spp., <i>Pseudomonas</i> spp., <i>Staphylococcus aureus</i> and <i>Streptococcus</i> spp.) were cultured as recommended by the Clinical Laboratory Standard Institute, using the Kirby Bauer disc diffusion method. Antimicrobial susceptibility testing was carried out on isolates using 15 different antibiotics.</p><p><strong>Results: </strong><i>Staphylococcus aureus</i> was the most frequent pathogen isolated 32.1% (50/156) and <i>Pseudomonas</i> spp. was the least frequent pathogen isolated 7.1% (11/156) in all samples. The isolates with the highest rate of resistance to the tested antibiotics were <i>S. aureus</i> 32.1% (50/156), <i>E. coli</i> 28.2% (44/156) and <i>Klebsiella</i> spp. 20.5% (32/156). Isolates in all age groups were more resistant to ampicillin, amoxicillin + clavulanic acid, cefuroxime and cefepime.</p><p><strong>Conclusion: </strong>Antibiotic resistance is high, especially the younger Nigerian children. Strict antibiotic protocols should be adhered to especially in the use of empirical antibiotic therapy in hospitals.</p><p><strong>What this study adds: </strong>Our study reveals a higher trend of antibiotic resistance, especially in younger children. It further shows that the pathogens are most resistant to the most available empirical antibiotics in Nigeria.</p>","PeriodicalId":45412,"journal":{"name":"African Journal of Laboratory Medicine","volume":"13 1","pages":"2362"},"PeriodicalIF":1.0,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11369577/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance comparison of three commercial multiplex molecular panels for respiratory viruses at a South African academic hospital. 南非一家学术医院呼吸道病毒三种商用多重分子检测板的性能比较。
IF 1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-20 eCollection Date: 2024-01-01 DOI: 10.4102/ajlm.v13i1.2415
Clinton van der Westhuizen, Mae Newton-Foot, Pieter Nel

Background: Respiratory infections are a major contributor to hospital admissions. Identification of respiratory pathogens by means of conventional culture and serology methods remains challenging. Multiplex molecular assays are an appealing alternative that endeavours to be rapid, more accurate and less arduous.

Objective: The study aimed to compare the clinical performance of three commercial multiplex molecular assays for respiratory viruses.

Methods: Forty-eight respiratory specimens obtained from patients at Tygerberg Hospital in the Western Cape province of South Africa were studied. These specimens were collected between May 2020 and August 2020. The results of the Seegene Anyplex™ II RV16, FilmArray® Respiratory 2.1 plus Panel (FARP), and QIAstat-Dx® Respiratory SARS-CoV-2 Panel (QRP) were analysed based on the overlapping targets. A composite reference standard was applied to provide a standard reference for comparison.

Results: The overall sensitivity of the Seegene Anyplex™ II RV16 was 96.6% (57/59), the FARP 98.2% (56/57) and the QRP 80.7% (46/57). The overall specificities were 99.8% (660/661), 99.0% (704/711) and 99.7% (709/711), respectively. The QRP failed to detect coronaviruses and parainfluenza viruses in 41.7% (5/12) and 28.6% (4/14) of positive specimens, respectively, while the FARP produced the lowest target specificity of 88.4% (38/43) for rhinovirus/enterovirus.

Conclusion: The overall specificity of all three platforms was comparable; however, the sensitivity of the QRP was inferior to that of the ARV and FARP.

What this study adds: This study adds to the body of performance characteristics described for respiratory multiplex panels, especially in the African context where molecular diagnostics for infectious diseases are gaining momentum.

背景:呼吸道感染是导致入院的主要原因。通过传统的培养和血清学方法鉴定呼吸道病原体仍然具有挑战性。多重分子检测是一种极具吸引力的替代方法,它力求快速、准确、简便:本研究旨在比较三种商用呼吸道病毒多重分子检测方法的临床性能:研究对象为南非西开普省泰格贝格医院的 48 份患者呼吸道标本。这些标本是在 2020 年 5 月至 2020 年 8 月期间采集的。根据重叠目标对 Seegene Anyplex™ II RV16、FilmArray® Respiratory 2.1 plus Panel (FARP) 和 QIAstat-Dx® Respiratory SARS-CoV-2 Panel (QRP) 的结果进行了分析。结果:Seegene Anyplex™ II RV16 的总体灵敏度为 96.6%(57/59),FARP 为 98.2%(56/57),QRP 为 80.7%(46/57)。总体特异性分别为 99.8%(660/661)、99.0%(704/711)和 99.7%(709/711)。QRP分别有41.7%(5/12)和28.6%(4/14)的阳性标本未能检测出冠状病毒和副流感病毒,而FARP对鼻病毒/肠病毒的目标特异性最低,仅为88.4%(38/43):结论:三种平台的总体特异性相当,但 QRP 的灵敏度低于 ARV 和 FARP:本研究的意义:本研究丰富了呼吸道多重检测平台的性能特征,尤其是在传染病分子诊断技术日益发展的非洲地区。
{"title":"Performance comparison of three commercial multiplex molecular panels for respiratory viruses at a South African academic hospital.","authors":"Clinton van der Westhuizen, Mae Newton-Foot, Pieter Nel","doi":"10.4102/ajlm.v13i1.2415","DOIUrl":"10.4102/ajlm.v13i1.2415","url":null,"abstract":"<p><strong>Background: </strong>Respiratory infections are a major contributor to hospital admissions. Identification of respiratory pathogens by means of conventional culture and serology methods remains challenging. Multiplex molecular assays are an appealing alternative that endeavours to be rapid, more accurate and less arduous.</p><p><strong>Objective: </strong>The study aimed to compare the clinical performance of three commercial multiplex molecular assays for respiratory viruses.</p><p><strong>Methods: </strong>Forty-eight respiratory specimens obtained from patients at Tygerberg Hospital in the Western Cape province of South Africa were studied. These specimens were collected between May 2020 and August 2020. The results of the Seegene Anyplex™ II RV16, FilmArray<sup>®</sup> Respiratory 2.1 <i>plus</i> Panel (FARP), and QIAstat-Dx<sup>®</sup> Respiratory SARS-CoV-2 Panel (QRP) were analysed based on the overlapping targets. A composite reference standard was applied to provide a standard reference for comparison.</p><p><strong>Results: </strong>The overall sensitivity of the Seegene Anyplex™ II RV16 was 96.6% (57/59), the FARP 98.2% (56/57) and the QRP 80.7% (46/57). The overall specificities were 99.8% (660/661), 99.0% (704/711) and 99.7% (709/711), respectively. The QRP failed to detect coronaviruses and parainfluenza viruses in 41.7% (5/12) and 28.6% (4/14) of positive specimens, respectively, while the FARP produced the lowest target specificity of 88.4% (38/43) for rhinovirus/enterovirus.</p><p><strong>Conclusion: </strong>The overall specificity of all three platforms was comparable; however, the sensitivity of the QRP was inferior to that of the ARV and FARP.</p><p><strong>What this study adds: </strong>This study adds to the body of performance characteristics described for respiratory multiplex panels, especially in the African context where molecular diagnostics for infectious diseases are gaining momentum.</p>","PeriodicalId":45412,"journal":{"name":"African Journal of Laboratory Medicine","volume":"13 1","pages":"2415"},"PeriodicalIF":1.0,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11369576/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of antimicrobial resistance surveillance in Ghana using the Integrated Disease Surveillance and Response strategy. 在加纳实施抗菌药耐药性监测,采用综合疾病监测和响应战略。
IF 1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-13 eCollection Date: 2024-01-01 DOI: 10.4102/ajlm.v13i1.2404
Beverly Egyir, Alfred Bortey, Kwabena O Duedu, Gifty Boateng, Franklin A Bekoe, George Hedidor, Michael Adjabeng, Nicholas T K D Dayie, Noah Obeng-Nkrumah, Japheth A Opintan
{"title":"Implementation of antimicrobial resistance surveillance in Ghana using the Integrated Disease Surveillance and Response strategy.","authors":"Beverly Egyir, Alfred Bortey, Kwabena O Duedu, Gifty Boateng, Franklin A Bekoe, George Hedidor, Michael Adjabeng, Nicholas T K D Dayie, Noah Obeng-Nkrumah, Japheth A Opintan","doi":"10.4102/ajlm.v13i1.2404","DOIUrl":"10.4102/ajlm.v13i1.2404","url":null,"abstract":"","PeriodicalId":45412,"journal":{"name":"African Journal of Laboratory Medicine","volume":"13 1","pages":"2404"},"PeriodicalIF":1.0,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11369569/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Invisible and undervalued: A qualitative study of laboratory workers' experiences and perceptions of laboratory strengthening in Sierra Leone. 无形和低估:塞拉利昂实验室工作人员对加强实验室工作的经验和看法的定性研究。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-05-31 eCollection Date: 2024-01-01 DOI: 10.4102/ajlm.v13i1.2292
Mohamed B Jalloh, Eva Vernooij, Alice Street

Background: The 2013-2016 West Africa Ebola outbreak highlighted the importance of laboratory capacity to outbreak response while also revealing its long-standing neglect. The outbreak prompted massive international investment into strengthening laboratory services across multiple healthcare settings.

Objective: In this article, we explore hospital-based clinical laboratory workers' experiences and perceptions of their everyday working environment in Sierra Leone, and how recent investments in laboratory strengthening have shaped these.

Methods: This qualitative study draws on in-depth interviews with eight laboratory workers and participant observation of laboratory practices at a tertiary referral hospital in Freetown between April 2019 and December 2019. Interview and observational data were coded and analysed using a reflexive thematic approach.

Results: The Ebola outbreak prompted international investments in automated devices, biosafety training, and a new dedicated infectious diseases laboratory. However, little investment was made in the infrastructure and supply systems needed to sustain routine laboratory work or keep machines functioning. Laboratory workers perceived their work to be under-recognised and undervalued by the government, hospital managers and clinical staff, a perception compounded by under-use of the hospital's laboratory services by clinicians.

Conclusion: Understanding laboratory technicians' views, experiences, and priorities is essential to any sustainable laboratory-strengthening effort. Investments in personnel should match investments in technologies and infrastructure for outbreak response.

What this study adds: This study contributes to an understanding of how clinical laboratory personnel in Sierra Leone view and experience their work, and introduces the concept of social invisibility to explain these experiences.

背景:2013-2016 年西非埃博拉疫情的爆发凸显了实验室能力对疫情应对的重要性,同时也暴露了实验室能力长期以来被忽视的问题。疫情爆发促使国际社会投入巨资,加强多种医疗机构的实验室服务:在这篇文章中,我们探讨了塞拉利昂医院临床实验室工作人员对其日常工作环境的体验和看法,以及近期对加强实验室服务的投资如何影响了这些体验和看法:这项定性研究利用了 2019 年 4 月至 2019 年 12 月期间对弗里敦一家三级转诊医院的 8 名实验室工作人员进行的深入访谈和对实验室实践的参与观察。采用反思性主题方法对访谈和观察数据进行编码和分析:埃博拉疫情爆发促使国际社会对自动化设备、生物安全培训和新的传染病专用实验室进行投资。然而,在维持常规实验室工作或保持机器正常运转所需的基础设施和供应系统方面却几乎没有投资。实验室工作人员认为他们的工作没有得到政府、医院管理人员和临床医护人员的充分认可和重视,而临床医生对医院实验室服务的使用不足又加剧了这种看法:结论:了解实验室技术人员的观点、经验和优先事项对于任何可持续的实验室强化工作都至关重要。对人员的投资应与对疫情应对技术和基础设施的投资相匹配:本研究有助于了解塞拉利昂临床实验室人员如何看待和体验他们的工作,并引入了社会隐匿性的概念来解释这些体验。
{"title":"Invisible and undervalued: A qualitative study of laboratory workers' experiences and perceptions of laboratory strengthening in Sierra Leone.","authors":"Mohamed B Jalloh, Eva Vernooij, Alice Street","doi":"10.4102/ajlm.v13i1.2292","DOIUrl":"10.4102/ajlm.v13i1.2292","url":null,"abstract":"<p><strong>Background: </strong>The 2013-2016 West Africa Ebola outbreak highlighted the importance of laboratory capacity to outbreak response while also revealing its long-standing neglect. The outbreak prompted massive international investment into strengthening laboratory services across multiple healthcare settings.</p><p><strong>Objective: </strong>In this article, we explore hospital-based clinical laboratory workers' experiences and perceptions of their everyday working environment in Sierra Leone, and how recent investments in laboratory strengthening have shaped these.</p><p><strong>Methods: </strong>This qualitative study draws on in-depth interviews with eight laboratory workers and participant observation of laboratory practices at a tertiary referral hospital in Freetown between April 2019 and December 2019. Interview and observational data were coded and analysed using a reflexive thematic approach.</p><p><strong>Results: </strong>The Ebola outbreak prompted international investments in automated devices, biosafety training, and a new dedicated infectious diseases laboratory. However, little investment was made in the infrastructure and supply systems needed to sustain routine laboratory work or keep machines functioning. Laboratory workers perceived their work to be under-recognised and undervalued by the government, hospital managers and clinical staff, a perception compounded by under-use of the hospital's laboratory services by clinicians.</p><p><strong>Conclusion: </strong>Understanding laboratory technicians' views, experiences, and priorities is essential to any sustainable laboratory-strengthening effort. Investments in personnel should match investments in technologies and infrastructure for outbreak response.</p><p><strong>What this study adds: </strong>This study contributes to an understanding of how clinical laboratory personnel in Sierra Leone view and experience their work, and introduces the concept of social invisibility to explain these experiences.</p>","PeriodicalId":45412,"journal":{"name":"African Journal of Laboratory Medicine","volume":"13 1","pages":"2292"},"PeriodicalIF":1.1,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11151379/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141263050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternally inherited diabetes and deafness with a variable presentation across three generations within a pedigree, South Africa. 母系遗传的糖尿病和耳聋,在一个血统中的三代人中表现各异,南非。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-05-29 eCollection Date: 2024-01-01 DOI: 10.4102/ajlm.v13i1.2384
Herbert Makgopa, Tanja Kemp, Surita Meldau, Engela M Honey, Bettina Chale-Matsau

Introduction: Maternally inherited diabetes and deafness (MIDD) is caused by the m.3243A>G pathogenic variant in maternally inherited mitochondrial DNA. Diabetes is prevalent in our setting; however, MIDD is rarely diagnosed. This study, undertaken in Pretoria, South Africa, highlights the variable presentation of MIDD in different patients within the same family.

Case presentation: A 45-year-old man (proband) with hearing impairment was referred to the endocrine unit in July 2015 due to poor glycaemic control (HbA1c = 13%). His clinical and biochemical features were in keeping with MIDD. A genetic study of accessible maternal relatives was pursued. His mother had difficulty hearing and reportedly died from an unspecified cardiovascular cause. Two sisters with diabetes and deafness died of cardiac-related conditions. One nephew had diabetes (HbA1c = 7.7%), hearing loss and tested positive for m.3243A>G. A third sister tested positive for m3243A>G, but aside from bilateral mild hearing loss in higher frequencies, showed no other signs of target organ damage. Her daughter developed end-stage kidney failure necessitating a transplant, while her son had no biochemical abnormalities and was negative for m.3243A>G.

Management and outcome: A multidisciplinary team managed and screened for complications of the patient and his maternal relatives. Proband died prior to genetic testing.

Conclusion: Most MIDD patients initially present with symptoms of diabetes only, and it is probable that many cases remain undiagnosed. A high index of suspicion is necessary when encountering a family history of both diabetes and impaired hearing, and screening should be offered to the patient's maternal relatives.

What the study adds: This study demonstrates the importance of proper assessment when evaluating a patient with diabetes and a family history of hearing loss.

简介母系遗传性糖尿病和耳聋(MIDD)是由母系遗传线粒体 DNA 中的 m.3243A>G 致病变异引起的。在我们的环境中,糖尿病很普遍,但 MIDD 却很少被诊断出来。这项在南非比勒陀利亚进行的研究强调了 MIDD 在同一家族不同患者中的不同表现形式:一名患有听力障碍的 45 岁男性(原发性)因血糖控制不佳(HbA1c = 13%)于 2015 年 7 月被转诊至内分泌科。他的临床和生化特征与 MIDD 一致。对可触及的母系亲属进行了遗传学研究。他的母亲有听力障碍,据说死于不明原因的心血管疾病。两个患有糖尿病和耳聋的姐妹死于心脏相关疾病。一个外甥患有糖尿病(HbA1c = 7.7%)、听力损失,m.3243A>G 检测呈阳性。第三个姐妹的 m3243A>G 检测呈阳性,但除了双侧高频轻度听力损失外,没有其他靶器官损伤的迹象。她的女儿出现终末期肾衰竭,需要进行移植手术,而她的儿子没有生化异常,m.3243A>G检测结果也呈阴性:多学科团队对患者及其母系亲属进行了管理和并发症筛查。Proband 在基因检测前死亡:大多数 MIDD 患者最初仅表现为糖尿病症状,可能还有很多病例未被诊断出来。当遇到同时有糖尿病和听力受损家族史的患者时,有必要高度怀疑,并对患者的母系亲属进行筛查:这项研究表明,在对有听力损失家族史的糖尿病患者进行评估时,正确评估非常重要。
{"title":"Maternally inherited diabetes and deafness with a variable presentation across three generations within a pedigree, South Africa.","authors":"Herbert Makgopa, Tanja Kemp, Surita Meldau, Engela M Honey, Bettina Chale-Matsau","doi":"10.4102/ajlm.v13i1.2384","DOIUrl":"10.4102/ajlm.v13i1.2384","url":null,"abstract":"<p><strong>Introduction: </strong>Maternally inherited diabetes and deafness (MIDD) is caused by the m.3243A>G pathogenic variant in maternally inherited mitochondrial DNA. Diabetes is prevalent in our setting; however, MIDD is rarely diagnosed. This study, undertaken in Pretoria, South Africa, highlights the variable presentation of MIDD in different patients within the same family.</p><p><strong>Case presentation: </strong>A 45-year-old man (proband) with hearing impairment was referred to the endocrine unit in July 2015 due to poor glycaemic control (HbA1c = 13%). His clinical and biochemical features were in keeping with MIDD. A genetic study of accessible maternal relatives was pursued. His mother had difficulty hearing and reportedly died from an unspecified cardiovascular cause. Two sisters with diabetes and deafness died of cardiac-related conditions. One nephew had diabetes (HbA1c = 7.7%), hearing loss and tested positive for m.3243A>G. A third sister tested positive for m3243A>G, but aside from bilateral mild hearing loss in higher frequencies, showed no other signs of target organ damage. Her daughter developed end-stage kidney failure necessitating a transplant, while her son had no biochemical abnormalities and was negative for m.3243A>G.</p><p><strong>Management and outcome: </strong>A multidisciplinary team managed and screened for complications of the patient and his maternal relatives. Proband died prior to genetic testing.</p><p><strong>Conclusion: </strong>Most MIDD patients initially present with symptoms of diabetes only, and it is probable that many cases remain undiagnosed. A high index of suspicion is necessary when encountering a family history of both diabetes and impaired hearing, and screening should be offered to the patient's maternal relatives.</p><p><strong>What the study adds: </strong>This study demonstrates the importance of proper assessment when evaluating a patient with diabetes and a family history of hearing loss.</p>","PeriodicalId":45412,"journal":{"name":"African Journal of Laboratory Medicine","volume":"13 1","pages":"2384"},"PeriodicalIF":1.1,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11151422/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141263052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Field study to determine the reliability of HIV viral load results shows minimal impact of delayed testing in South Africa. 旨在确定艾滋病毒病毒载量结果可靠性的实地研究表明,在南非,延迟检测的影响微乎其微。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-05-28 eCollection Date: 2024-01-01 DOI: 10.4102/ajlm.v13i1.2364
Diana R Hardie, Howard Newman, Joanna Reid, Nei-Yuan Hsiao, Gert van Zyl, Lucia Hans, Jasantha Odayar, Stephen Korsman

Background: Understanding factors that impact HIV viral load (VL) accuracy in resource-limited settings is key to quality improvement.

Objective: We evaluated whether testing delay and specimen storage between 25 °C and 30 °C before testing affected results.

Methods: Between November 2019 and June 2023, 249 individuals on antiretroviral therapy, or with newly diagnosed HIV, were recruited from clinics in Cape Town and Gqeberha, South Africa, and three plasma preparation tubes were collected. One tube was tested within 24 h, while the others were stored uncentrifuged at ambient temperatures before testing. Centrifugation and testing of matched samples were performed on Day 4 and Day 7 after collection.

Results: Time delay and ambient storage had minimal impact in specimens with a Day 1 VL of > 100 copies/mL. When grouped by Day 1 VL range, 96% - 100% of specimens at Day 4 and 93% - 100% at Day 7 had VLs within 0.5 log copies/mL of the first result. The greatest variability at Days 4 and 7 was observed when the Day 1 VL was < 100 copies/mL. However, there was no trend of increasing difference over time. Of Day 1 specimens with undetectable VL, or VL < 50 copies/mL, 80% had concordant results at Day 4 and 78% at Day 7.

Conclusion: These results show that VL is stable in plasma preparation tubes for 7 days when stored at room temperature. There is significant variability in specimens with low VL, but variability is not affected by testing delay.

What this study adds: Ideal HIV VL testing conditions are frequently unachievable in resource-limited settings. Data are needed on whether this impacts on the validity of test results. Our results provide reassurance that storage at ambient temperature for up to 7 days before testing does not substantially affect the VL result.

背景:了解在资源有限的环境中影响 HIV 病毒载量(VL)准确性的因素是提高质量的关键:在资源有限的环境中,了解影响 HIV 病毒载量(VL)准确性的因素是提高质量的关键:我们评估了检测延迟和检测前标本在 25 °C 和 30 °C 之间的储存是否会影响检测结果:2019年11月至2023年6月期间,我们从南非开普敦和盖贝哈的诊所招募了249名正在接受抗逆转录病毒治疗或新确诊感染艾滋病毒的患者,并收集了三管血浆制备样本。其中一管在 24 小时内进行检测,其他血浆在检测前未经离心储存在环境温度下。采集后第 4 天和第 7 天对匹配样本进行离心和检测:结果:时间延迟和常温保存对第 1 天 VL > 100 拷贝/毫升的样本影响很小。如果按第 1 天 VL 范围分组,第 4 天 96% - 100% 的标本和第 7 天 93% - 100% 的标本的 VL 都在首次结果的 0.5 log copies/mL 以内。当第 1 天的 VL 小于 100 拷贝/毫升时,第 4 天和第 7 天的变异性最大。然而,随着时间的推移,差异没有增加的趋势。在第 1 天检测不到 VL 或 VL < 50 拷贝/毫升的标本中,第 4 天 80% 的结果一致,第 7 天 78% 的结果一致:这些结果表明,血浆制备试管在室温下保存 7 天,VL 是稳定的。低 VL 标本的变异性很大,但变异性不受检测延迟的影响:本研究的补充:在资源有限的环境中,理想的 HIV VL 检测条件往往无法实现。我们需要数据来说明这是否会影响检测结果的有效性。我们的研究结果再次证明,检测前在环境温度下储存 7 天不会对 VL 结果产生重大影响。
{"title":"Field study to determine the reliability of HIV viral load results shows minimal impact of delayed testing in South Africa.","authors":"Diana R Hardie, Howard Newman, Joanna Reid, Nei-Yuan Hsiao, Gert van Zyl, Lucia Hans, Jasantha Odayar, Stephen Korsman","doi":"10.4102/ajlm.v13i1.2364","DOIUrl":"10.4102/ajlm.v13i1.2364","url":null,"abstract":"<p><strong>Background: </strong>Understanding factors that impact HIV viral load (VL) accuracy in resource-limited settings is key to quality improvement.</p><p><strong>Objective: </strong>We evaluated whether testing delay and specimen storage between 25 °C and 30 °C before testing affected results.</p><p><strong>Methods: </strong>Between November 2019 and June 2023, 249 individuals on antiretroviral therapy, or with newly diagnosed HIV, were recruited from clinics in Cape Town and Gqeberha, South Africa, and three plasma preparation tubes were collected. One tube was tested within 24 h, while the others were stored uncentrifuged at ambient temperatures before testing. Centrifugation and testing of matched samples were performed on Day 4 and Day 7 after collection.</p><p><strong>Results: </strong>Time delay and ambient storage had minimal impact in specimens with a Day 1 VL of > 100 copies/mL. When grouped by Day 1 VL range, 96% - 100% of specimens at Day 4 and 93% - 100% at Day 7 had VLs within 0.5 log copies/mL of the first result. The greatest variability at Days 4 and 7 was observed when the Day 1 VL was < 100 copies/mL. However, there was no trend of increasing difference over time. Of Day 1 specimens with undetectable VL, or VL < 50 copies/mL, 80% had concordant results at Day 4 and 78% at Day 7.</p><p><strong>Conclusion: </strong>These results show that VL is stable in plasma preparation tubes for 7 days when stored at room temperature. There is significant variability in specimens with low VL, but variability is not affected by testing delay.</p><p><strong>What this study adds: </strong>Ideal HIV VL testing conditions are frequently unachievable in resource-limited settings. Data are needed on whether this impacts on the validity of test results. Our results provide reassurance that storage at ambient temperature for up to 7 days before testing does not substantially affect the VL result.</p>","PeriodicalId":45412,"journal":{"name":"African Journal of Laboratory Medicine","volume":"13 1","pages":"2364"},"PeriodicalIF":1.1,"publicationDate":"2024-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11151376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141263048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sentinel laboratory compliance with best practices in Burkina Faso's antimicrobial resistance surveillance network. 布基纳法索抗菌药耐药性监测网络中的哨点实验室遵守最佳做法的情况。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-30 eCollection Date: 2024-01-01 DOI: 10.4102/ajlm.v13i1.2259
Dame Yenyetou, Emmanuel Zongo, Emilie Dama, Merci Muhigwa, Issouf Sanou, Charles Sawadogo, Soumaya Ouangraoua, Ibrahim Sangare, Abdoulaye Nikiema, Anicet G Dahourou, Abdoul S Ouedraogo

Background: Standardising procedures is the best way to harmonise and strengthen the quality of laboratory-based antimicrobial resistance surveillance. Since 2018, Burkina Faso has developed and disseminated the national manual of procedures for performing antibiotic susceptibility tests in sentinel laboratories within its national antimicrobial resistance surveillance network.

Objective: Our study aimed to assess these sentinel laboratories' compliance with good practices for antibiotics susceptibility tests.

Methods: Four teams evaluated the antimicrobial resistance sentinel sites laboratories throughout Burkina Faso from 19 to 28 September 2022. Eighteen out of 19 sentinel laboratories were evaluated. A four-member technical committee designed and validated the evaluation tool composed of three Microsoft Excel sheets. The evaluation emphasised quality controls for culture media, antibiotic discs and compliance with antimicrobial susceptibility testing procedures by the laboratories. Excel software was used for data recording and graphs and table design. The free R software version 4.2.0 was used for descriptive statistics. An overall score below 80% was considered noncompliance.

Results: Most (83.33%) of the sentinel laboratories conducted at least one quality control activity for culture media, and 66.67% conducted at least one quality control activity for antibiotic discs. Over three-quarters (76.47%) of the laboratories were more than 80% compliant with the modified Kirby Bauer antimicrobial susceptibility testing method.

Conclusion: The evaluation revealed the noncompliance of sentinel laboratories with the national procedure manual, particularly in the quality control component.

What this study adds: This study has provided baseline data on the sentinel laboratories' compliance with the national antimicrobial susceptibility testing procedures manual, particularly in areas performing quality control checks or meeting quality indicators for culture media and antibiotic discs.

背景:程序标准化是协调和加强基于实验室的抗菌药物耐药性监测质量的最佳途径。自 2018 年以来,布基纳法索在其国家抗菌药物耐药性监测网络内的哨点实验室中编制并分发了国家抗生素药敏试验程序手册:我们的研究旨在评估这些哨点实验室对抗生素药敏试验良好操作规范的遵守情况:2022 年 9 月 19 日至 28 日,四个小组对布基纳法索全国的抗菌药物耐药性哨点实验室进行了评估。对 19 个哨点实验室中的 18 个进行了评估。由四人组成的技术委员会设计并验证了由三张 Microsoft Excel 表单组成的评估工具。评估强调了对培养基、抗生素盘的质量控制,以及实验室对抗菌药物敏感性检测程序的遵守情况。Excel 软件用于数据记录、图表设计。免费的 R 软件 4.2.0 版用于描述性统计。总得分低于 80% 的实验室被视为不符合要求:大多数哨点实验室(83.33%)至少开展了一次培养基质量控制活动,66.67%至少开展了一次抗生素盘质量控制活动。超过四分之三(76.47%)的实验室对改良柯比鲍尔抗菌药物敏感性检测方法的符合率超过 80%:评估结果表明,哨点实验室不符合国家程序手册的要求,尤其是在质量控制部分:这项研究提供了哨点实验室遵守国家抗菌药物药敏试验程序手册的基线数据,尤其是在执行质量控制检查或达到培养基和抗生素盘质量指标方面。
{"title":"Sentinel laboratory compliance with best practices in Burkina Faso's antimicrobial resistance surveillance network.","authors":"Dame Yenyetou, Emmanuel Zongo, Emilie Dama, Merci Muhigwa, Issouf Sanou, Charles Sawadogo, Soumaya Ouangraoua, Ibrahim Sangare, Abdoulaye Nikiema, Anicet G Dahourou, Abdoul S Ouedraogo","doi":"10.4102/ajlm.v13i1.2259","DOIUrl":"10.4102/ajlm.v13i1.2259","url":null,"abstract":"<p><strong>Background: </strong>Standardising procedures is the best way to harmonise and strengthen the quality of laboratory-based antimicrobial resistance surveillance. Since 2018, Burkina Faso has developed and disseminated the national manual of procedures for performing antibiotic susceptibility tests in sentinel laboratories within its national antimicrobial resistance surveillance network.</p><p><strong>Objective: </strong>Our study aimed to assess these sentinel laboratories' compliance with good practices for antibiotics susceptibility tests.</p><p><strong>Methods: </strong>Four teams evaluated the antimicrobial resistance sentinel sites laboratories throughout Burkina Faso from 19 to 28 September 2022. Eighteen out of 19 sentinel laboratories were evaluated. A four-member technical committee designed and validated the evaluation tool composed of three Microsoft Excel sheets. The evaluation emphasised quality controls for culture media, antibiotic discs and compliance with antimicrobial susceptibility testing procedures by the laboratories. Excel software was used for data recording and graphs and table design. The free R software version 4.2.0 was used for descriptive statistics. An overall score below 80% was considered noncompliance.</p><p><strong>Results: </strong>Most (83.33%) of the sentinel laboratories conducted at least one quality control activity for culture media, and 66.67% conducted at least one quality control activity for antibiotic discs. Over three-quarters (76.47%) of the laboratories were more than 80% compliant with the modified Kirby Bauer antimicrobial susceptibility testing method.</p><p><strong>Conclusion: </strong>The evaluation revealed the noncompliance of sentinel laboratories with the national procedure manual, particularly in the quality control component.</p><p><strong>What this study adds: </strong>This study has provided baseline data on the sentinel laboratories' compliance with the national antimicrobial susceptibility testing procedures manual, particularly in areas performing quality control checks or meeting quality indicators for culture media and antibiotic discs.</p>","PeriodicalId":45412,"journal":{"name":"African Journal of Laboratory Medicine","volume":"13 1","pages":"2259"},"PeriodicalIF":1.1,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839167/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139698550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fighting cervical cancer in Africa: Taking a closer look at human papillomavirus 35. 在非洲防治宫颈癌:仔细研究人类乳头瘤病毒 35。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-29 eCollection Date: 2024-01-01 DOI: 10.4102/ajlm.v13i1.2243
Sophia U Okeke
{"title":"Fighting cervical cancer in Africa: Taking a closer look at human papillomavirus 35.","authors":"Sophia U Okeke","doi":"10.4102/ajlm.v13i1.2243","DOIUrl":"10.4102/ajlm.v13i1.2243","url":null,"abstract":"","PeriodicalId":45412,"journal":{"name":"African Journal of Laboratory Medicine","volume":"13 1","pages":"2243"},"PeriodicalIF":1.1,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839236/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139698612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
African Journal of Laboratory Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1